Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IPM9
PDB structure(s): 7ane_s
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.438 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.495 |
CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 89 | 91 | PF00082 | 0.421 |
CLV_PCSK_PC1ET2_1 | 89 | 91 | PF00082 | 0.421 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.635 |
DOC_PP2B_LxvP_1 | 21 | 24 | PF13499 | 0.434 |
DOC_SPAK_OSR1_1 | 151 | 155 | PF12202 | 0.466 |
DOC_USP7_UBL2_3 | 135 | 139 | PF12436 | 0.423 |
DOC_WW_Pin1_4 | 159 | 164 | PF00397 | 0.494 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.411 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.560 |
LIG_APCC_ABBAyCdc20_2 | 35 | 41 | PF00400 | 0.407 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.412 |
LIG_EVH1_2 | 163 | 167 | PF00568 | 0.547 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.413 |
LIG_LIR_Gen_1 | 165 | 174 | PF02991 | 0.604 |
LIG_LIR_Gen_1 | 60 | 71 | PF02991 | 0.530 |
LIG_LIR_Gen_1 | 95 | 105 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.441 |
LIG_LIR_Nem_3 | 95 | 100 | PF02991 | 0.413 |
LIG_SH2_CRK | 113 | 117 | PF00017 | 0.550 |
LIG_SH2_STAP1 | 118 | 122 | PF00017 | 0.403 |
LIG_SH2_STAP1 | 97 | 101 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.404 |
LIG_WRC_WIRS_1 | 63 | 68 | PF05994 | 0.427 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.416 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.511 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.481 |
MOD_CK2_1 | 92 | 98 | PF00069 | 0.410 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.492 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.448 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.477 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.394 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.528 |
MOD_N-GLC_1 | 155 | 160 | PF02516 | 0.579 |
MOD_N-GLC_1 | 92 | 97 | PF02516 | 0.411 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.607 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.487 |
MOD_NEK2_2 | 118 | 123 | PF00069 | 0.387 |
MOD_PKA_1 | 145 | 151 | PF00069 | 0.476 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.563 |
MOD_Plk_1 | 118 | 124 | PF00069 | 0.389 |
MOD_Plk_1 | 92 | 98 | PF00069 | 0.426 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.579 |
MOD_ProDKin_1 | 159 | 165 | PF00069 | 0.500 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.411 |
MOD_SUMO_rev_2 | 41 | 48 | PF00179 | 0.434 |
TRG_ENDOCYTIC_2 | 113 | 116 | PF00928 | 0.406 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.424 |
TRG_ER_diArg_1 | 35 | 38 | PF00400 | 0.399 |
TRG_NLS_MonoExtC_3 | 87 | 92 | PF00514 | 0.424 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1V0 | Leptomonas seymouri | 93% | 100% |
A0A0S4INE8 | Bodo saltans | 66% | 100% |
A0A1X0NLW0 | Trypanosomatidae | 88% | 99% |
A0A3S5IS76 | Trypanosoma rangeli | 88% | 99% |
A4HFD6 | Leishmania braziliensis | 96% | 100% |
A4I358 | Leishmania infantum | 99% | 100% |
C9ZKV7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 89% | 99% |
E9ACZ5 | Leishmania major | 99% | 100% |
E9AYS0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
V5BBN9 | Trypanosoma cruzi | 89% | 72% |